PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 44.10
0.00 (0.00%)
Oct 2, 2026, 5:30 PM CET
PolyPeptide Group AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,456 | 861 | 937 | 577 | 834 | 4,525 | |
Market Cap Growth | 85.43% | -8.08% | 62.30% | -30.79% | -81.57% | - |
Enterprise Value | 1,539 | 893 | 1,002 | 655 | 799 | 4,381 |
Last Close Price | 44.10 | 26.10 | 28.40 | 17.52 | 25.32 | 136.52 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 107.85 | - | - | - | 108.66 | 92.36 |
Forward PE | 39.04 | 96.37 | 147.50 | 237.88 | 26.86 | 76.21 |
PS Ratio | 3.44 | 2.38 | 2.97 | 1.94 | 3.00 | 15.47 |
PB Ratio | 4.49 | 2.72 | 2.80 | 1.63 | 2.00 | 10.36 |
P/TBV Ratio | 4.58 | 2.83 | 2.92 | 1.70 | 2.08 | 10.73 |
P/FCF Ratio | - | - | 273.70 | - | - | - |
P/OCF Ratio | 29.72 | 11.93 | 11.17 | 17.00 | 154.57 | 76.11 |
PEG Ratio | - | 20.12 | 20.12 | 20.12 | 6.25 | 2.92 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.63 | 2.47 | 3.17 | 2.20 | 2.88 | 14.98 |
EV/EBITDA Ratio | 20.76 | 25.19 | 58.41 | - | 24.45 | 50.64 |
EV/EBIT Ratio | 37.75 | 113.30 | - | - | 64.52 | 62.70 |
EV/FCF Ratio | - | - | 292.65 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.43 | 0.42 | 0.29 | 0.33 | 0.08 | 0.07 |
Debt / EBITDA Ratio | 1.86 | 3.29 | 4.61 | - | 0.87 | 0.34 |
Debt / FCF Ratio | - | - | 28.75 | - | - | - |
Net Debt / Equity Ratio | 0.26 | 0.20 | 0.10 | 0.08 | -0.01 | -0.25 |
Net Debt / EBITDA Ratio | 1.20 | 1.75 | 2.00 | -2.36 | -0.18 | -1.28 |
Net Debt / FCF Ratio | -1.81 | -2.21 | 10.04 | -1.77 | 0.08 | 6.43 |
Asset Turnover | 0.56 | 0.49 | 0.47 | 0.51 | 0.48 | 0.58 |
Inventory Turnover | 2.21 | 2.16 | 2.18 | 2.31 | 1.78 | 1.76 |
Quick Ratio | 0.76 | 0.87 | 0.90 | 1.09 | 1.04 | 2.04 |
Current Ratio | 1.64 | 1.74 | 1.69 | 1.85 | 2.62 | 3.19 |
Return on Equity (ROE) | 4.24% | -6.07% | -5.30% | -12.81% | 1.84% | 15.78% |
Return on Assets (ROA) | 3.38% | 0.67% | -0.52% | -3.34% | 1.34% | 8.68% |
Return on Invested Capital (ROIC) | 5.75% | 2.11% | -1.48% | -8.19% | 3.43% | 20.21% |
Return on Capital Employed (ROCE) | 6.80% | 1.30% | -1.10% | -6.60% | 2.60% | 13.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.92% | -2.29% | -1.96% | -8.29% | 0.92% | 1.08% |
FCF Yield | -3.15% | -3.27% | 0.36% | -2.65% | -8.25% | -0.38% |
Dividend Yield | - | - | - | - | - | 0.22% |
Payout Ratio | - | - | - | - | 124.51% | - |
Buyback Yield / Dilution | 1.93% | -0.09% | -0.10% | 0.11% | -2.74% | -7.08% |
Total Shareholder Return | 1.93% | -0.09% | -0.10% | 0.11% | -2.74% | -6.86% |